465 Diagnostics, Treatments and Theranostics

Wednesday, November 11, 2015: 8:30 AM - 11:00 AM
250A (Salt Palace Convention Center)

Description:
This session explores the contributions of chemical engineers to the development and commercialization of diagnostics, treatments and theranostics. Contributions from image contrast agents to the design of new medicines welcome.

Sponsor:
Chemical Engineers in Medicine
Co-Sponsor(s):
Food, Pharmaceutical & Bioengineering Division (15), Pharmaceuticals (15B), Bioengineering (15C), Engineering Fundamentals in Life Science (15D)
Chair:
David W. Grainger Email: david.grainger@utah.edu
Co-Chair:
Leonard F. Pease III Email: pease@eng.utah.edu
- indicates paper has an Extended Abstract file available on CD.



8:30 AM
(465a) High-Throughput Biomimetic Assay Designed to Quantify Antimalarial Efficacy
Megan Ketchum, Jeffrey D. Rimer and Peter G. Vekilov


8:51 AM
(465b) Utility of DNA Capture Resins in the Development of Minimally Invasive Tools for Genetic Monitoring of Pancreatic Health
Andrew J. Hilmer, Walter Park, R. Brooke Jeffrey and Chaitan Khosla


9:12 AM
(465c) Fluorophore-Gold Nanoparticle Contrast Agent for Specific and Sensitive MMP-14 Detection
Mai-Dung Nguyen, Palaniappan Sethu and Kyung A. Kang

File available
9:33 AM
(465d) Design and Simulation of an Automated Rare Blood Cell Detector
Zhixi Qian, Eugene Boland, Paul W. Todd and Thomas R. Hanley


9:54 AM
(465e) Biofilm Mitigation on Implanted Devices
Erica Ricker, Ann O'Toole, Bryce Hundley and Eric Nuxoll


10:15 AM
(465f) Second Window Near Infrared Fluorescent Imaging for Deep Tissue Animal Imaging
Xiangnan Dang and Angela M. Belcher


10:36 AM
(465g) Specifically Tuned Light Activated Nano-Therapeutics for Selective Killing of Multi Drug Resistant Bacterial Strains
Colleen Courtney, Samuel Goodman, Prashant Nagpal and Anushree Chatterjee
See more of this Group/Topical: Topical Conference: Chemical Engineers in Medicine
<< Previous Session | Next Session >>